PHASE I STUDY OF CABAZITAXEL IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS: A POETIC GROUP STUDY

被引：0
|
作者：
Manley, P. [1 ]
Trippett, T. [2 ]
Smith, A. [3 ]
Macy, M. [4 ]
Leary, S. [5 ,6 ]
Boklan, J. [7 ]
Cohen, K. [8 ]
Shen, L. [9 ]
Herzog, C. [10 ]
Veyrat-Follet, C. [11 ]
Zhang, J. [12 ]
Chi, S. [1 ]
机构：
[1] Dana Farber Canc Inst, Pediat Oncol, Boston, MA 02115 USA
[2] Mem Sloan Kettering Canc Ctr, Pediat Hematol Oncol, New York, NY 10021 USA
[3] Arnold Palmer Med Ctr, Pediat Hematol Oncol, Orlando, FL USA
[4] Univ Colorado, Childrens Hosp Colorado, Pediat Hematol Oncol, Aurora, CO USA
[5] Seattle Childrens Univ Washington, Seattle, WA USA
[6] Fred Hutchinson Canc Res Ctr, Pediat Hematol Oncol, Seattle, WA 98104 USA
[7] Phoenix Childrens Hosp, Pediat Hematol Oncol, Phoenix, AZ USA
[8] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Pediat Hematol Oncol, Baltimore, MD USA
[9] Sanofi US, Sanofi Oncol, Bridgewater, MA USA
[10] Univ Texas MD Anderson Canc Ctr, Pediat Hematol Oncol, Houston, TX 77030 USA
[11] Sanofi, Drug Disposit Disposit Safety & Anim Res Dept, Vitry Sur Seine, France
[12] Sanofi, Sanofi Oncol, Cambridge, MA USA
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-049
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [1] A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: A children's oncology group study
    Weigel, Brenda J.
    Blaney, Susan M.
    Reid, Joel M.
    Safgren, Stephanie L.
    Bagatell, Rochelle
    Kersey, John
    Neglia, Joseph P.
    Ivy, S. Percy
    Ingle, Ashish M.
    Whitesell, Luke
    Gilbertson, Richard J.
    Krailo, Mark
    Ames, Matthew
    Adamson, Peter C.
    CLINICAL CANCER RESEARCH, 2007, 13 (06) : 1789 - 1793
  • [2] A Phase I study of acivicin in refractory pediatric solid tumors - A Pediatric Oncology Group study
    Baruchel, S
    Bernstein, M
    Whitehead, VM
    Devine, S
    Bell, B
    Dubowy, R
    Grier, H
    Kretschmar, C
    Langevin, AM
    Vietti, T
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (03) : 211 - 216
  • [3] Phase I study of everolimus in pediatric patients with refractory solid tumors
    Fouladi, Maryam
    Laningham, Fred
    Wu, Jianrong
    O'Shaughnessy, Melinda A.
    Molina, Kristen
    Broniscer, Alberto
    Spunt, Sheri L.
    Luckett, Inga
    Stewart, Clinton F.
    Houghton, Peter J.
    Gilbertson, Richard J.
    Furman, Wayne L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4806 - 4812
  • [4] Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors
    Meany, Holly J.
    Widemann, Brigitte C.
    Hinds, Pamela S.
    Bagatell, Rochelle
    Shusterman, Suzanne
    Stern, Emily
    Jayaprakash, Nalini
    Peer, Cody J.
    Figg, William D.
    Hall, O. Morgan
    Sissung, Tristan M.
    Kim, Aerang
    Fox, Elizabeth
    London, Wendy B.
    Rodriguez-Galindo, Carlos
    Minturn, Jane E.
    Dome, Jeffrey S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (11)
  • [5] A phase I trial and pharmacokinetic study of IMC-A12 in pediatric patients with relapsed/refractory solid tumors: A Children's Oncology Group Phase I Consortium study
    Malempati, S.
    Weigel, B.
    Ingle, A. M.
    Ahern, C. H.
    Carroll, J. M.
    Roberts, C. T., Jr.
    Fox, F. E.
    Voss, S.
    Adamson, P. C.
    Blaney, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] A phase I study of oxaliplatin and etoposide in pediatric patients with refractory solid tumors
    McGregor, L. M.
    Spunt, S. L.
    Santana, V. M.
    Stewart, C. F.
    Ward, D. A.
    Wu, J.
    Watkins, A.
    Ivy, S. P.
    Furman, W. L.
    Fouladi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase I study of DMP 840 in pediatric patients with refractory solid tumors
    Thompson, J
    Pratt, CB
    Stewart, CF
    Avery, L
    Bowman, L
    Zamboni, WC
    Pappo, A
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 45 - 49
  • [8] Phase I study of DMP 840 in pediatric patients with refractory solid tumors
    Joyce Thompson
    Charles B. Pratt
    Clinton F. Stewart
    Loraine Avery
    Laura Bowman
    William C. Zamboni
    Alberto Pappo
    Investigational New Drugs, 1998, 16 : 45 - 49
  • [9] Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors
    Spunt, Sheri L.
    Grupp, Stephan A.
    Vik, Terry A.
    Santana, Victor M.
    Greenblatt, David J.
    Clancy, Jill
    Berkenblit, Anna
    Krygowski, Mizue
    Ananthakrishnan, Revathi
    Boni, Joseph P.
    Gilbertson, Richard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) : 2933 - 2940
  • [10] Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
    DuBois, Steven G.
    Shusterman, Suzanne
    Ingle, Ashish M.
    Ahern, Charlotte H.
    Reid, Joel M.
    Wu, Bing
    Baruchel, Sylvain
    Glade-Bender, Julia
    Ivy, Percy
    Grier, Holcombe E.
    Adamson, Peter C.
    Blaney, Susan M.
    CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5113 - 5122
12345